NEW YORK (GenomeWeb News) – Metabolon said today that it is collaborating with researchers at the University of Texas Health Science Center at San Antonio on the development of Metabolon’s pre-diabetes diagnostic products.
Research Triangle Park, NC-based Metabolon will analyze samples from studies being conducted by Ralph DeFronzo and his colleagues at UTHSC in an effort to discover and validate biochemical biomarkers reflective of insulin resistance and beta cell dysfunction. The markers will be used by Metabolon to develop diagnostic tests for insulin resistance and how this relates to the risk of developing metabolic diseases, such as diabetes.
Metabolon hopes to develop a test that can help physicians “identify asymptomatic, pre-diabetic patients years before they become diabetic,” John Ryals, CEO of Metablon, said in a statement.
Further terms of the alliance were not disclosed.